Næste

Automatisk afspilning

PM1183 plus doxorubicin shows interesting activity in small cell lung cancer

2 Visninger • 07/14/23
Del
Indlejre
administrator
administrator
Abonnenter
0

Visit http://www.ecancer.org for more

Dr Calvo (START Madrid, Madrid, Spain) talks to ecancertv at ASCO 2015 about data from a Phase 1b study of the transcriptional inhibitor PM1183 in combination with doxorubicin in second line therapy in patients with small cell lung cancer (SCLC)

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning